Table 2.
Biomarker and Culture Results of Serum and BALF for Patients Who Met the Definition of Probable Aspergillus Infection
| Patient | BALF GM | Serum GM | Serum BDG | Serum PCR | BALF PCR | BALF Culture >104 cfu/ml |
|---|---|---|---|---|---|---|
| 1 | 14.67 | 1.22 | + | + | + | Aspergillus sp.* |
| 2 | 13.95 | 0.21 | + | − | + | Acinetobacter sp. |
| 3 | 11.59 | 0.50 | + | − | + | A. fumigatus* |
| 4 | 8.46 | 0.04 | − | − | + | M. catarrhalis |
| 5 | 8.04 | 0.11 | + | + | + | A. fumigatus* |
| 6 | 4.66 | 0.08 | − | − | − | — |
| 7 | 3.32 | 0.12 | − | − | − | E. coli |
| 8 | 3.16 | 0.07 | − | − | − | K. pneumoniae |
| 9 | 2.40 | 0.08 | + | − | − | P. mirabilis |
| 10 | 2.02 | 0.03 | − | − | − | — |
| 11 | 1.65 | 0.05 | − | − | − | P. aeruginosa |
| 12 | 1.52 | 0.05 | − | − | − | S. aureus |
| 13 | 1.47 | 0.17 | + | − | − | — |
| 14 | 1.47 | 0.08 | − | − | − | — |
| 15 | 1.44 | 0.08 | − | − | − | — |
| 16 | 1.41 | 0.05 | − | + | − | — |
| 17 | 1.36 | 0.18 | − | − | − | — |
| 18 | 1.24 | 0.52 | + | − | + | — |
| 19 | 1.05 | 0.21 | − | + | + | — |
| 20 | 1.03 | 0.51 | + | + | − | — |
| 21 | 0.14 | 2.65 | + | − | − | E. cloacae |
| 22 | 0.32 | 1.54 | − | − | + | — |
| 23 | 0.43 | 0.79 | − | − | + | S. aureus, S. marcescens |
| 24 | 0.92 | 0.50 | + | − | − | — |
Definition of abbreviations: A. fumigatus = Aspergillus fumigatus; BALF = BAL fluid; BDG = β-d-glucan; E. cloacae = Enterobacter cloacae; E. coli = Escherichia coli; GM = galactomannan; K. pneumoniae = Klebsiella pneumoniae; M. catarrhalis = Moraxella catarrhalis; P. aeruginosa = Pseudomonas aeruginosa; P. mirabilis = Proteus mirabilis; S. aureus = Staphylococcus aureus; S. marcescens = Serratia marcescens.
*
Any growth of Aspergillus sp. reported (no minimum cfu/ml applied).